• Rose Hill Life Sciences Appoints Jama Pitman as Strategic Advisor citybiz Mon, 05 May 2025 14:48:51 GMT
• Ono Pharma lays off 83 staffers at Cambridge, Massachusetts, site Fierce Biotech Tue, 29 Apr 2025 17:56:09 GMT
• AACR: Topical gel relieves painful skin rash side effect caused by targeted therapy for colorectal cancer MD Anderson Cancer Center Sun, 27 Apr 2025 22:06:38 GMT
• Tenosynovial Giant Cell Tumors Pipeline 2025: FDA Updates, openPR.com Fri, 25 Apr 2025 07:00:00 GMT
• Gastrointestinal Stromal Tumor Market to Grow Rapidly During the Study Period (2020–2034) Owing to the Launch of Emerging Therapie... Yahoo Finance Tue, 15 Apr 2025 07:00:00 GMT
• ira mellman joins pici; viiv healthcare cmo replaces chris corsico at gsk Endpoints News Fri, 11 Apr 2025 11:00:00 GMT
• From $2.4B Exit to Next Biotech Success: Pharma Veteran Steve Hoerter Strengthens MBX Board Stock Titan Mon, 07 Apr 2025 07:00:00 GMT
• mbx biosciences appoints veteran pharmaceutical executive steve hoerter to board of directors The Manila Times Mon, 07 Apr 2025 07:00:00 GMT
• tenosynovial giant cell tumors treatment market size in 7mm openPR.com Wed, 02 Apr 2025 11:10:00 GMT
• deciphera stock soars after ono pharmaceutical’s $2.4b buyout deal MSN Wed, 02 Apr 2025 09:31:11 GMT
• graft versus host disease market is projected for substantial expansion from usd 1.3 billion in 2023| delveinsight The Globe and Mail Thu, 13 Mar 2025 07:00:00 GMT
• FDA Approval Insights: Vimseltinib for Symptomatic TGCT: With William D. Tap, MD OncLive Thu, 06 Mar 2025 08:00:00 GMT
• deciphera pharmaceuticals, inc. to host earnings call ACCESS Newswire Thu, 06 Mar 2025 04:41:48 GMT
• ono's romvimza approval shakes up tenosynovial giant cell tumors market, challenging daiichi sankyo's turalio dominance | delveins... The Malaysian Reserve Wed, 05 Mar 2025 08:00:00 GMT
• ono's romvimza approval shakes up tenosynovial giant cell tumors market, challenging daiichi sankyo's turalio dominance | delveins... The Malaysian Reserve Tue, 04 Mar 2025 23:10:48 GMT
• genetic testing role gastroenterology cancer gi Clinical Oncology News Wed, 26 Feb 2025 11:03:54 GMT
• Fierce Pharma Asia—Novo Nordisk's fraud accusation; AstraZeneca's China deal; Ono's FDA nod Fierce Pharma Fri, 21 Feb 2025 08:00:00 GMT
• FDA Approves Romvimza for Symptomatic Tenosynovial Giant Cell Tumor Specialty Pharmacy Continuum Thu, 20 Feb 2025 15:33:55 GMT
• industry outlook 2025: personalizing precision medicine and adopting ai Pharmaceutical Technology Magazine Thu, 20 Feb 2025 12:00:51 GMT
• FDA Approves Romvimza for Symptomatic Tenosynovial Giant Cell Tumor Clinical Oncology News Wed, 19 Feb 2025 08:00:00 GMT
• fda approves vimseltinib for tenosynovial giant cell tumor (tgct) On Cancer - Memorial Sloan Kettering Wed, 19 Feb 2025 08:00:00 GMT
• Ono Pharma Drug Acquired in $2.4B Deal Wins FDA Approval for Treating Rare Type of Tumor MedCity News Tue, 18 Feb 2025 08:00:00 GMT
• FDA Approves Onos Romvimza for Rare Tumors After Deciphera Buyout Precedence Research Tue, 18 Feb 2025 08:00:00 GMT
• Deciphera’s Romvimza wins FDA nod for tenosynovial giant cell tumors BioWorld MedTech Tue, 18 Feb 2025 08:00:00 GMT
• Ono’s FDA Rare Cancer Approval Sets Up Face Off With Daiichi Sankyo BioSpace Mon, 17 Feb 2025 08:00:00 GMT
• us fda approves deciphera’s romvimza for tgct treatment Pharmaceutical Business review - Mon, 17 Feb 2025 08:00:00 GMT
• u.s. fda grants full approval of deciphera’s romvimza™ (vimseltinib) for the treatment of symptomatic tenosynovial giant cell tumo... BioSpace Mon, 17 Feb 2025 06:20:19 GMT
• ono pharmaceutical co., ltd. announces u.s. food and drug administration approval of deciphera's romvimza?? for the treatment of s... Marketscreener.com Sat, 15 Feb 2025 03:20:08 GMT
• ono wins fda approval for tgct treatment gained via deciphera takeout FirstWord Pharma Sat, 15 Feb 2025 00:00:21 GMT
• fda approves vimseltinib for the treatment of adults with symptomatic tgct Pharmacy Times Fri, 14 Feb 2025 21:16:52 GMT
• FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout Fierce Pharma Fri, 14 Feb 2025 08:00:00 GMT
• U.S. FDA Grants Full Approval of Deciphera’s ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumo... Business Wire Fri, 14 Feb 2025 08:00:00 GMT
• Ono wins FDA approval for TGCT treatment gained via Deciphera takeout FirstWord Pharma Fri, 14 Feb 2025 08:00:00 GMT
• FDA Approves Vimseltinib for Tenosynovial Giant Cell Tumors Medscape Fri, 14 Feb 2025 08:00:00 GMT
• fda approves vimseltinib for symptomatic tenosynovial giant cell tumor -february 14, 2025 at 03:51 pm est Marketscreener.com Fri, 14 Feb 2025 08:00:00 GMT
• ono pharmaceutical co., ltd. announces u.s. food and drug administration approval of deciphera's romvimza?? for the treatment of s... Marketscreener.com Fri, 14 Feb 2025 08:00:00 GMT
• sustainability in inhalation and small-molecule drugs Pharmaceutical Technology Magazine Thu, 30 Jan 2025 08:00:00 GMT
• dcph stock earnings: deciphera pharmaceuticals beats eps, misses revenue for q1 2024 MSN Sat, 18 Jan 2025 03:59:23 GMT
• wall street analysts believe deciphera pharmaceuticals, inc. (dcph) could rally 59.63%: here's is how to trade MSN Fri, 17 Jan 2025 03:10:07 GMT
• RAF inhibitors described in Deciphera Pharmaceuticals patent BioWorld MedTech Tue, 14 Jan 2025 08:00:00 GMT
• 2024 pharma and biotech m&a deals exceed 2023 in numbers but not value The Pharma Letter Fri, 03 Jan 2025 08:00:00 GMT
• inhibitors of perk and gcn2 disclosed in deciphera patent BioWorld MedTech Mon, 23 Dec 2024 08:00:00 GMT
• the impact of usp chapter on endotoxin testing Pharmaceutical Technology Magazine Wed, 11 Dec 2024 08:00:00 GMT
• behind the headlines: pandemic preparedness, novel mrna applications, and more Pharmaceutical Technology Magazine Tue, 03 Dec 2024 08:00:00 GMT
• kras inhibitor market size was ~usd 500 million in 2023, which is expected to rise significantly by 2034 EIN News Thu, 28 Nov 2024 07:09:00 GMT
• c4 therapeutics appoints accomplished oncology executive steve hoerter to board of directors GlobeNewswire Wed, 20 Nov 2024 08:00:00 GMT
• c4 therapeutics adds oncology veteran steve hoerter to board, brings drug launch expertise StockTitan Wed, 20 Nov 2024 08:00:00 GMT
• fierce pharma asia—merck and biontech's i-o bispecific buys; az ceo's china defense FiercePharma Fri, 15 Nov 2024 08:00:00 GMT
• tenosynovial giant cell tumors clinical trials 2024: ema, pdma, openPR Wed, 13 Nov 2024 08:00:00 GMT
• Abbisko, Merck KGaA drug hits main goal of pivotal study in rare tumour type FirstWord Pharma Tue, 12 Nov 2024 08:00:00 GMT
• Merck KGaA's phase 3 rare tumor trial hits goal, teeing up rivalry with Daiichi and Ono Fierce Biotech Tue, 12 Nov 2024 08:00:00 GMT
• equillium keeps equilibrium in gvhd after ono no-go BioWorld MedTech Thu, 31 Oct 2024 07:00:00 GMT
• Deciphera’s GCN2 activator shows activity in solid tumors BioWorld MedTech Wed, 30 Oct 2024 07:00:00 GMT
• regulatory collaboration on mpox treatments summarized in report Pharmaceutical Technology Magazine Fri, 25 Oct 2024 07:00:00 GMT
• ligachem biosciences appoints rodrigo ruiz soto as chief medical officer Business Wire Wed, 23 Oct 2024 07:00:00 GMT
• tenosynovial giant cell tumors pipeline insights and analysis 2024: fda approvals, therapies, moa, roa, and developments | deciphe... The Globe and Mail Fri, 18 Oct 2024 13:37:14 GMT
• tyrosine protein kinase lyn market is going to boom |ab science sa, boehringer ingelheim gmbh, deciphera pharmaceuticals – indiapo... IndiaPolitics.com Wed, 16 Oct 2024 10:16:34 GMT
• aaps pharmsci 360 2024: predictive models for poorly soluble drugs Pharmaceutical Technology Magazine Thu, 10 Oct 2024 07:00:00 GMT
• vegfr-2 antagonists clinical trial pipeline insights featuring 25+ companies | delveinsight GlobeNewswire Tue, 08 Oct 2024 07:00:00 GMT
• kras inhibitors market: new treatments are set to change cancer care | delveinsight GlobeNewswire Mon, 30 Sep 2024 07:00:00 GMT
• vimseltinib shows efficacy in rare tenosynovial giant cell tumors OncLive Mon, 09 Sep 2024 07:00:00 GMT
• astrocytoma treatment drug market to witness upsurge in growth during the study period (2020-2034) | delveinsight PR Newswire Wed, 21 Aug 2024 07:00:00 GMT
• fda accepts nda and priority review application for vimseltinib in tenosynovial giant cell tumors Pharmacy Times Tue, 20 Aug 2024 07:00:00 GMT
• fda accepts deciphera's vimseltinib nda for priority review Pharmaceutical Technology Fri, 16 Aug 2024 10:20:28 GMT
• FDA accepts Deciphera’s vimseltinib NDA for priority review Pharmaceutical Technology Fri, 16 Aug 2024 07:00:00 GMT
• FDA Grants Priority Review to Vimseltinib in Tenosynovial Giant Cell Tumor OncLive Fri, 16 Aug 2024 07:00:00 GMT
• Vimseltinib Earns FDA Priority Review in Tenosynovial Giant Cell Tumor Cancer Network Fri, 16 Aug 2024 07:00:00 GMT
• FDA Grants Priority Review to Vimseltinib Application in Tenosynovial Giant Cell Tumor Targeted Oncology Fri, 16 Aug 2024 07:00:00 GMT
• nanoform and takeda to collaborate on plasma-derived therapy formulation Pharmaceutical Technology Magazine Fri, 16 Aug 2024 07:00:00 GMT
• U.S. Food and Drug Administration Accepts for Priority Review Deciphera’s New Drug Application for Vimseltinib for the Treatment o... Business Wire Thu, 15 Aug 2024 07:00:00 GMT
• gastric cancer drugs market size to reach usd 12.5 billion by 2032, impelled by the increasing health consciousness BioSpace Thu, 08 Aug 2024 07:00:00 GMT
• public employees retirement system of ohio buys new shares in deciphera pharmaceuticals, inc. (nasdaq:dcph) Defense World Wed, 07 Aug 2024 08:55:53 GMT
• vanguard group inc. raises holdings in deciphera pharmaceuticals, inc. (nasdaq:dcph) Defense World Tue, 06 Aug 2024 14:14:01 GMT
• deciphera pharmaceuticals, inc. (nasdaq:dcph) shares sold by lazard asset management llc Defense World Sat, 03 Aug 2024 07:00:00 GMT
• state board of administration of florida retirement system buys 1,570 shares of deciphera pharmaceuticals, inc. (nasdaq:dcph) Defense World Wed, 31 Jul 2024 17:46:39 GMT
• russell investments group ltd. reduces position in deciphera pharmaceuticals, inc. (nasdaq:dcph) Defense World Wed, 31 Jul 2024 14:08:56 GMT
• ono keeps making moves with new german partnership The Pharma Letter Wed, 31 Jul 2024 07:00:00 GMT
• proshare advisors llc has $240,000 stake in deciphera pharmaceuticals, inc. (nasdaq:dcph) Defense World Mon, 29 Jul 2024 10:08:14 GMT
• deciphera pharmaceuticals, inc. (nasdaq:dcph) shares acquired by swiss national bank Defense World Thu, 25 Jul 2024 12:28:35 GMT
• bnp paribas financial markets sells 41,173 shares of deciphera pharmaceuticals, inc. (nasdaq:dcph) Defense World Mon, 22 Jul 2024 10:27:16 GMT
• mirae asset global investments co. ltd. sells 9,157 shares of deciphera pharmaceuticals, inc. (nasdaq:dcph) Defense World Sat, 20 Jul 2024 10:51:14 GMT
• EMA accepts Deciphera’s MAA for cell tumour treatment for review Pharmaceutical Technology Fri, 19 Jul 2024 07:00:00 GMT
• eu approval sought for vimseltinib in tenosynovial giant cell tumor OncLive Fri, 19 Jul 2024 07:00:00 GMT
• european medicines agency accepts deciphera’s marketing authorization application for vimseltinib for treatment of patients with t... TT Nyhetsbyrån Fri, 19 Jul 2024 07:00:00 GMT
• European Medicines Agency Accepts Deciphera’s Marketing Authorization Application for Vimseltinib for Treatment of Patients with T... Business Wire Thu, 18 Jul 2024 07:00:00 GMT
• biopharma deals bring in $97b in first half of 2024, outpacing last year BioWorld Online Tue, 16 Jul 2024 07:00:00 GMT
• deciphera pharmaceuticals, inc. (nasdaq:dcph) receives average rating of “hold” from brokerages Defense World Sat, 13 Jul 2024 05:26:38 GMT
• gsa capital partners llp sells 80,011 shares of deciphera pharmaceuticals, inc. (nasdaq:dcph) Defense World Fri, 12 Jul 2024 11:53:42 GMT
• biopharma deals bring in $97b in first half of 2024, outpacing last year BioWorld Online Fri, 12 Jul 2024 07:00:00 GMT
• gsa capital partners llp reduces stock position in deciphera pharmaceuticals, inc. (nasdaq:dcph) American Banking and Market News Fri, 12 Jul 2024 07:00:00 GMT
• capstone investment advisors llc purchases new shares in deciphera pharmaceuticals, inc. (nasdaq:dcph) Defense World Tue, 09 Jul 2024 07:00:00 GMT
• diversified trust co increases position in deciphera pharmaceuticals, inc. (nasdaq:dcph) Defense World Sat, 06 Jul 2024 09:07:24 GMT
• deciphera (dcph) gets breakthrough tag for qinlock expanded use Yahoo New Zealand News Sun, 30 Jun 2024 06:05:12 GMT
• is the options market predicting a spike in deciphera (dcph) stock? Yahoo News UK Thu, 27 Jun 2024 04:00:00 GMT
• options traders expect huge moves in deciphera pharmaceuticals (dcph) stock Yahoo News UK Thu, 27 Jun 2024 03:42:11 GMT
• liposarcoma market outlook report 2032 | novartis ag, eli lilly openPR Tue, 25 Jun 2024 07:00:00 GMT
• deciphera pharmaceuticals, inc. (nasdaq:dcph) analysts just trimmed their revenue forecasts by 14% Yahoo Movies UK Mon, 24 Jun 2024 17:34:41 GMT
• agulnik highlights key updates in gist research and management OncLive Mon, 24 Jun 2024 07:00:00 GMT
• brodsky & smith shareholder update: notifying investors of GlobeNewswire Mon, 24 Jun 2024 07:00:00 GMT
• fisher asset management llc acquires shares of 62,372 deciphera pharmaceuticals, inc. (nasdaq:dcph) MarketBeat Sun, 23 Jun 2024 18:21:51 GMT
• fisher asset management llc purchases shares of 62372 deciphera pharmaceuticals, inc. (nasdaq:dcph) Defense World Sun, 23 Jun 2024 10:55:06 GMT
• fisher asset management llc buys shares of 62,372 deciphera pharmaceuticals, inc. (nasdaq:dcph) MarketBeat Sun, 23 Jun 2024 07:00:00 GMT
• deciphera pharmaceuticals, inc. (nasdaq:dcph) shares bought by goldman sachs group inc. MarketBeat Sat, 22 Jun 2024 20:18:20 GMT
• is the options market predicting a spike in deciphera (dcph) stock? Yahoo News UK Sat, 22 Jun 2024 15:26:35 GMT
• deciphera announces health canada's authorization of qinlock Reuters Sat, 22 Jun 2024 07:00:00 GMT
• deciphera pharmaceuticals, inc. (nasdaq:dcph) analysts just trimmed their revenue forecasts by 14% Yahoo Movies UK Thu, 20 Jun 2024 11:31:24 GMT
• why is deciphera pharmaceuticals, inc. (dcph) down 10.8% since last earnings report? Yahoo Sport Australia Thu, 20 Jun 2024 07:07:48 GMT
• deciphera pharma stock plunges after disappointing trial results Yahoo News Australia Thu, 20 Jun 2024 04:56:00 GMT
• brodsky & smith shareholder update: notifying investors of the following investigations: rbaz bancorp, inc ... GlobeNewswire Tue, 18 Jun 2024 15:03:42 GMT
• deciphera pharmaceuticals is being acquired and the stock soars 72% MSN Tue, 18 Jun 2024 12:27:15 GMT
• deciphera pharmaceuticals, inc. (nasdaq:dcph) given consensus rating of “hold” by brokerages Defense World Tue, 18 Jun 2024 07:00:00 GMT
• deciphera pharmaceuticals, inc. (nasdaq:dcph) receives $24.17 consensus target price from analysts MarketBeat Tue, 18 Jun 2024 05:37:52 GMT
• deciphera pharmaceuticals, inc. (nasdaq:dcph) shares acquired by frazier life sciences management l.p. MarketBeat Thu, 13 Jun 2024 22:05:45 GMT
• tenosynovial giant cell tumors market to exhibit substantial growth rate during the forecast period | elixiron, daiichi sankyo, am... Barchart Thu, 13 Jun 2024 07:00:00 GMT
• braidwell lp trims position in deciphera pharmaceuticals, inc. (nasdaq:dcph) MarketBeat Wed, 12 Jun 2024 20:04:20 GMT
• braidwell lp has $18.86 million position in deciphera pharmaceuticals, inc. (nasdaq:dcph) MarketBeat Wed, 12 Jun 2024 20:04:20 GMT
• deciphera pharmaceuticals, inc. (nasdaq:dcph) shares bought by nebula research & development llc MarketBeat Tue, 11 Jun 2024 17:58:50 GMT
• dcph - deciphera pharmaceuticals, inc. latest stock news & market updates StockTitan Tue, 11 Jun 2024 12:30:00 GMT
• Ono Announces Results of Tender Offer to Acquire Deciphera Pharmaceuticals and Completion of Acquisition of Deciphera (a Wholly Ow... PR Newswire Tue, 11 Jun 2024 07:00:00 GMT
• deciphera pharmaceuticals: significant post-merger corporate changes TipRanks Tue, 11 Jun 2024 07:00:00 GMT
• ono pharmaceutical wraps up $2.4 billion deciphera buyout Investing.com Tue, 11 Jun 2024 07:00:00 GMT
• ono pharmaceutical closes deciphera deal for about $2.4b MarketWatch Tue, 11 Jun 2024 07:00:00 GMT
• ono pharmaceutical completes tender offer for deciphera (nasdaq:dcph) Seeking Alpha Tue, 11 Jun 2024 07:00:00 GMT
• citi maintains neutral on fifth third, price target at $40 by investing.com Investing.com Tue, 11 Jun 2024 07:00:00 GMT
• nebula research & development llc has $1.04 million holdings in deciphera pharmaceuticals, inc. (nasdaq:dcph) MarketBeat Tue, 11 Jun 2024 07:00:00 GMT
Deciphera Pharmaceuticals, Inc(NASDAQ:DCPH) 